2022
Measuring coping in multiple sclerosis: The Coping Index-MS (Journal article)
Young, C. A., Mills, R. J., Langdon, D., Rog, D. J., Sharrack, B., Kalra, S., . . . Tennant, A. (2022). Measuring coping in multiple sclerosis: The Coping Index-MS. MULTIPLE SCLEROSIS JOURNAL, 28(14), 2274-2284. doi:10.1177/13524585221114004DOI: 10.1177/13524585221114004
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months (Journal article)
Young, C. A., Ealing, J., McDermott, C. J., Williams, T. L., Al-Chalabi, A., Majeed, T., . . . Tennant, A. (2022). Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. doi:10.1080/21678421.2022.2096410DOI: 10.1080/21678421.2022.2096410
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12 (Journal article)
Young, C. A., Ealing, J., McDermott, C. J., Williams, T. L., Al-Chalabi, A., Majeed, T., . . . Tennant, A. (2022). Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. doi:10.1080/21678421.2022.2102926DOI: 10.1080/21678421.2022.2102926
Understanding quality of life across different clinical subtypes of multiple sclerosis: a thematic analysis (Journal article)
Ando, H., Cousins, R., & Young, C. A. (2022). Understanding quality of life across different clinical subtypes of multiple sclerosis: a thematic analysis. QUALITY OF LIFE RESEARCH, 31(7), 2035-2046. doi:10.1007/s11136-021-03041-7DOI: 10.1007/s11136-021-03041-7
Flexibility to manage and enhance quality of life among people with motor neurone disease (Journal article)
Ando, H., Cousins, R., & Young, C. A. (2022). Flexibility to manage and enhance quality of life among people with motor neurone disease. DISABILITY AND REHABILITATION, 44(12), 2752-2762. doi:10.1080/09638288.2020.1846797DOI: 10.1080/09638288.2020.1846797
Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles (Journal article)
Young, C., Pinto, S., Grosskreutz, J., Hardiman, O., Clawson, L. L., Cudkowicz, M. E., & Andrews, J. A. (2022). Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 23(1-2), 66-75. doi:10.1080/21678421.2021.1920981DOI: 10.1080/21678421.2021.1920981
Balendra, R., Jones, A. R., Al Khleifat, A., Chiwera, T., Wicks, P., Young, C. A., . . . Al-Chalabi, A. (2022). Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. doi:10.1080/21678421.2022.2090847DOI: 10.1080/21678421.2022.2090847
2021
Letter to the editor re: the effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients Altunan et al., IJUN, (2021) 53:1059 (Journal article)
McNicholas, D. P., Floyd, M. S. J., Mann, K. R., Khadr, R. N., & Young, C. A. (2021). Letter to the editor re: the effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients Altunan et al., IJUN, (2021) 53:1059. INTERNATIONAL UROLOGY AND NEPHROLOGY, 53(11), 2297-2298. doi:10.1007/s11255-021-02958-9DOI: 10.1007/s11255-021-02958-9
2020
Saxon, J. A., Thompson, J. C., Harris, J. M., Richardson, A. M., Langheinrich, T., Rollinson, S., . . . Snowden, J. S. (2020). Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 91(12), 1304-1311. doi:10.1136/jnnp-2020-323969DOI: 10.1136/jnnp-2020-323969
Letter to the editor re: Worsening disability status in multiple sclerosis predicts urologic complications. Int Urol Nephrol. May; 52(5):859-863. doi: 10.1007/s11255-020-02381-6. Epub 2020 Jan 25 by Abello et al (Journal article)
Floyd, M. S. J., Khadr, R. N., & Young, C. A. (2020). Letter to the editor re: Worsening disability status in multiple sclerosis predicts urologic complications. Int Urol Nephrol. May; 52(5):859-863. doi: 10.1007/s11255-020-02381-6. Epub 2020 Jan 25 by Abello et al. INTERNATIONAL UROLOGY AND NEPHROLOGY, 52(12), 2307-2308. doi:10.1007/s11255-020-02551-6DOI: 10.1007/s11255-020-02551-6
Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations (Journal article)
Tanti, M., Cairns, D., Mirza, N., McCann, E., & Young, C. (2020). Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations. NEUROGENETICS, 21(4), 305-308. doi:10.1007/s10048-020-00619-0DOI: 10.1007/s10048-020-00619-0
Saxon, J. A., Thompson, J. C., Harris, J. M., Ealing, J., Hamdalla, H., Chaouch, A., . . . Snowden, J. S. (2020). The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. doi:10.1080/21678421.2020.1797090DOI: 10.1080/21678421.2020.1797090
Pomeroy, I. M., Tennant, A., Mills, R. J., & Young, C. A. (2020). The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis. QUALITY OF LIFE RESEARCH, 29(7), 1961-1972. doi:10.1007/s11136-020-02463-zDOI: 10.1007/s11136-020-02463-z
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF (Journal article)
Young, C. A., Mills, R., Al-Chalabi, A., Burke, G., Chandran, S., Dick, D. J., . . . TONiC study group. (n.d.). Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic lateral sclerosis & frontotemporal degeneration. doi:10.1080/21678421.2020.1752244DOI: 10.1080/21678421.2020.1752244
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis (Journal article)
James, E., Young, C. A., Gibbons, E. L., Shueb, A., & Tur, C. (n.d.). Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013599DOI: 10.1002/14651858.cd013599
Edge, R., Mills, R., Tennant, A., Diggle, P. J., Young, C. A., Al-Chalabi, A., . . . Harrower, T. (2020). Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. JOURNAL OF NEUROLOGY, 267(3), 607-615. doi:10.1007/s00415-019-09615-3DOI: 10.1007/s00415-019-09615-3
Edge, R., Mills, R., Tennant, A., Diggle, P. J., Young, C. A., Al-Chalabi, A., . . . Harrower, T. (2020). Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature (vol 267, pg 607, 2020). JOURNAL OF NEUROLOGY, 267(3), 616-617. doi:10.1007/s00415-020-09700-yDOI: 10.1007/s00415-020-09700-y
Chataway, J., De Angelis, F., Connick, P., Parker, R. A., Plantone, D., Doshi, A., . . . McLean, B. (2020). Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. LANCET NEUROLOGY, 19(3), 214-225. doi:10.1016/S1474-4422(19)30485-5DOI: 10.1016/S1474-4422(19)30485-5
Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT (Journal article)
Hepgul, N., Wilson, R., Yi, D., Evans, C., Bajwah, S., Crosby, V., . . . Gao, W. (2020). Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT.
2019
Health Utilities and Costs for Motor Neurone Disease (Journal article)
Moore, A., Young, C. A., & Hughes, D. A. (2019). Health Utilities and Costs for Motor Neurone Disease. VALUE IN HEALTH, 22(11), 1257-1265. doi:10.1016/j.jval.2019.05.011DOI: 10.1016/j.jval.2019.05.011
Giebel, C., Medley, G., Smith, S., Thornton, M., Furlong, M., Ennis, M., & Young, C. (2019). Communicating psychosocial well-being in motor neurone disease to staff: results from a World Cafe approach. QUALITY OF LIFE RESEARCH, 28(9), 2579-2584. doi:10.1007/s11136-019-02193-xDOI: 10.1007/s11136-019-02193-x
Experience of telehealth in people with motor neurone disease using noninvasive ventilation. (Journal article)
Ando, H., Ashcroft-Kelso, H., Halhead, R., Chakrabarti, B., Young, C. A., Cousins, R., & Angus, R. M. (2019). Experience of telehealth in people with motor neurone disease using noninvasive ventilation.. Disability and rehabilitation. Assistive technology, 1-7. doi:10.1080/17483107.2019.1659864DOI: 10.1080/17483107.2019.1659864
Schluter, D. K., Holland, D. P., Mills, R. J., McDermott, C. J., Williams, T. L., & Young, C. A. (2019). Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics. ACTA NEUROLOGICA SCANDINAVICA, 140(2), 131-139. doi:10.1111/ane.13113DOI: 10.1111/ane.13113
Adroher, N. D., Kreiner, S., Young, C., Mills, R., & Tennant, A. (2019). Test equating sleep scales: applying the Leunbach's model. BMC MEDICAL RESEARCH METHODOLOGY, 19. doi:10.1186/s12874-019-0768-yDOI: 10.1186/s12874-019-0768-y
Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent) (Journal article)
Ando, H., Ashcroft-Kelso, H., Halhead, R., Young, C. A., Chakrabarti, B., Levene, P., . . . Angus, R. M. (2019). Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(5-6), 336-347. doi:10.1080/21678421.2019.1587630DOI: 10.1080/21678421.2019.1587630
Young, C. A., Ealing, J., Mcdermott, C., Williams, T., Al-chalabi, A., Majeed, T., . . . Tennant, A. (2019). The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. doi:10.1080/21678421.2019.1615951DOI: 10.1080/21678421.2019.1615951
Holland, D. P., Schluter, D. K., Young, C. A., Mills, R. J., Rog, D. J., Ford, H. L., & Orchard, K. (2019). Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 27, 214-222. doi:10.1016/j.msard.2018.10.016DOI: 10.1016/j.msard.2018.10.016
2018
Schluter, D. K., Tennant, A., Mills, R., Diggle, P. J., Young, C. A., & Grp, T. S. (2018). Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 19(7-8), 591-598. doi:10.1080/21678421.2018.1508477DOI: 10.1080/21678421.2018.1508477
Moore, A., Young, C. A., & Hughes, D. A. (2018). Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. VALUE IN HEALTH, 21(11), 1322-1329. doi:10.1016/j.jval.2018.05.005DOI: 10.1016/j.jval.2018.05.005
Connick, P., De Angelis, F., Parker, R. A., Plantone, D., Doshi, A., John, N., . . . UK Multiple Sclerosis Society Clinical Trials Network. (2018). Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.. BMJ open, 8(8), e021944. doi:10.1136/bmjopen-2018-021944DOI: 10.1136/bmjopen-2018-021944
Development and validation of Spasticity IndexAmyotrophic Lateral Sclerosis (Journal article)
Milinis, K., Tennant, A., Mills, R. J., Al-Chalabi, A., Burke, G., Dick, D. J., . . . Young, C. A. (2018). Development and validation of Spasticity IndexAmyotrophic Lateral Sclerosis. ACTA NEUROLOGICA SCANDINAVICA, 138(1), 47-54. doi:10.1111/ane.12910DOI: 10.1111/ane.12910
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. (Journal article)
Kapoor, R., Ho, P. -R., Campbell, N., Chang, I., Deykin, A., Forrestal, F., . . . ASCEND investigators. (2018). Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.. The Lancet. Neurology, 17(5), 405-415. doi:10.1016/s1474-4422(18)30069-3DOI: 10.1016/s1474-4422(18)30069-3
Quality of life for post-polio syndrome: a patient derived, Rasch standard scale (Journal article)
Young, C. A., Quincey, A. -M. C., Wong, S. M., & Tennant, A. (n.d.). Quality of life for post-polio syndrome: a patient derived, Rasch standard scale. DISABILITY AND REHABILITATION, 40(5), 597-602. doi:10.1080/09638288.2016.1260650DOI: 10.1080/09638288.2016.1260650
Measuring Physical and Cognitive Fatigue in People With Post-Polio Syndrome: Development of the Neurological Fatigue Index for Post-Polio Syndrome (NFI-PP) (Journal article)
Young, C. A., Wong, S. M., Quincey, A. -M. C., & Tennant, A. (2018). Measuring Physical and Cognitive Fatigue in People With Post-Polio Syndrome: Development of the Neurological Fatigue Index for Post-Polio Syndrome (NFI-PP). PM&R, 10(2), 129-136. doi:10.1016/j.pmrj.2017.06.014DOI: 10.1016/j.pmrj.2017.06.014
Gibbons, C., Pagnini, F., Friede, T., & Young, C. A. (2018). Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD011005.pub2DOI: 10.1002/14651858.CD011005.pub2
2017
van Eijk, R. P. A., Jones, A. R., Sproviero, W., Shatunov, A., Shaw, P. J., Leigh, P. N., . . . Grp, U. K. M. N. D. -L. I. C. A. L. S. L. I. T. A. L. S. S. (2017). Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. NEUROLOGY, 89(18), 1915-1922. doi:10.1212/WNL.0000000000004606DOI: 10.1212/WNL.0000000000004606
Sexual functioning in multiple sclerosis: Relationships with depression, fatigue and physical function (Journal article)
Young, C. A., Tennant, A., & Grp, T. S. (2017). Sexual functioning in multiple sclerosis: Relationships with depression, fatigue and physical function. MULTIPLE SCLEROSIS JOURNAL, 23(9), 1268-1275. doi:10.1177/1352458516675749DOI: 10.1177/1352458516675749
Fang, T., Al Khleifat, A., Stahl, D. R., Lazo La Torre, C., Murphy, C., Uk-Mnd LicalS., . . . Al-Chalabi, A. (2017). Comparison of the King's and MiToS staging systems for ALS.. Amyotrophic lateral sclerosis & frontotemporal degeneration, 18(3-4), 227-232. doi:10.1080/21678421.2016.1265565DOI: 10.1080/21678421.2016.1265565
Economic Studies in Motor Neurone Disease: A Systematic Methodological Review (Journal article)
Moore, A., Young, C. A., & Hughes, D. A. (2017). Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PHARMACOECONOMICS, 35(4), 397-413. doi:10.1007/s40273-016-0478-9DOI: 10.1007/s40273-016-0478-9
Rasch analysis of SF-Qualiveen in multiple sclerosis (Journal article)
Milinis, K., Tennant, A., & Young, C. A. (2017). Rasch analysis of SF-Qualiveen in multiple sclerosis. NEUROUROLOGY AND URODYNAMICS, 36(4), 1161-1166. doi:10.1002/nau.23081DOI: 10.1002/nau.23081
Ng, L., Khan, F., Young, C. A., & Galea, M. (2017). Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD011776.pub2DOI: 10.1002/14651858.CD011776.pub2
Mcgeachan, A. J., Hobson, E. V., Al-Chalabi, A., Stephenson, J., Chandran, S., Crawley, F., . . . Mcdermott, C. J. (2017). A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 18(1-2), 1-9. doi:10.1080/21678421.2016.1221433DOI: 10.1080/21678421.2016.1221433
2016
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions (Journal article)
Milinis, K., & Young, C. A. (2016). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. DISABILITY AND REHABILITATION, 38(15), 1431-1441. doi:10.3109/09638288.2015.1106592DOI: 10.3109/09638288.2015.1106592
McDermott, C. J., Bradburn, M. J., Maguire, C., Cooper, C. L., Baird, W. O., Baxter, S. K., . . . Shaw, P. J. (2016). DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial. HEALTH TECHNOLOGY ASSESSMENT, 20(45), 1-+. doi:10.3310/hta20450DOI: 10.3310/hta20450
van Vliet, L. M., Gao, W., DiFrancesco, D., Crosby, V., Wilcock, A., Byrne, A., . . . Neuro, O. P. T. C. A. R. E. (2016). How integrated are neurology and palliative care services? Results of a multicentre mapping exercise. BMC NEUROLOGY, 16. doi:10.1186/s12883-016-0583-6DOI: 10.1186/s12883-016-0583-6
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis (Journal article)
Warrender-Sparkes, M., Spelman, T., Izquierdo, G., Trojano, M., Lugaresi, A., Grand'Maison, F., . . . Jokubaitis, V. (2016). The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 22(4), 520-532. doi:10.1177/1352458515594041DOI: 10.1177/1352458515594041
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group (Journal article)
McGuigan, C., Craner, M., Guadagno, J., Kapoor, R., Mazibrada, G., Molyneux, P., . . . Young, C. A. (2016). Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 87(2), 117-125. doi:10.1136/jnnp-2015-311100DOI: 10.1136/jnnp-2015-311100
Comparative health status and quality of life between Primary and Secondary Progressive Multiple Sclerosis (Conference Paper)
Young, C. A., Mills, R. J., & Tennant, A. (2016). Comparative health status and quality of life between Primary and Secondary Progressive Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 58). Retrieved from https://www.webofscience.com/
Comparative health status and quality of life between Relapsing Remitting and Progressive Multiple Sclerosis (Conference Paper)
Young, C. A., Mills, R. J., & Tennant, A. (2016). Comparative health status and quality of life between Relapsing Remitting and Progressive Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 29). Retrieved from https://www.webofscience.com/
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life (Journal article)
Milinis, K., Tennant, A., & Young, C. A. (2016). Spasticity in multiple sclerosis: Associations with impairments and overall quality of life. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 5, 34-39. doi:10.1016/j.msard.2015.10.007DOI: 10.1016/j.msard.2015.10.007
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life (Journal article)
Milinis, K., Tennant, A., & Young, C. A. (2016). Spasticity in multiple sclerosis: Associations with impairments and overall quality of life. Multiple Sclerosis and Related Disorders, 5, 34-39. doi:10.1016/j.msard.2015.10.007DOI: 10.1016/j.msard.2015.10.007
Mills, R. J., Tennant, A., & Young, C. A. (2016). The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.. Multiple sclerosis journal - experimental, translational and clinical, 2, 2055217316642263. doi:10.1177/2055217316642263DOI: 10.1177/2055217316642263
2015
Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease (Journal article)
Hoo, F. K., Hasan Sumon, M. S., Basri, H., Wan Sulaiman, W. A., Stanslas, J., Zaman Hashim, H., & Young, C. A. (n.d.). Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012000DOI: 10.1002/14651858.cd012000
Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis (Journal article)
van der Kleij, L. A., Jones, A. R., Steen, I. N., Young, C. A., Shaw, P. J., Shaw, C. E., . . . Al-Chalabi, A. (2015). Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 16(7-8), 442-447. doi:10.3109/21678421.2015.1051987DOI: 10.3109/21678421.2015.1051987
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder (Journal article)
Mutch, K., Zhao, S., Hamid, S., Methley, A., Elsone, L., Singh, G., . . . Jacob, A. (2015). Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 4(6), 614-618. doi:10.1016/j.msard.2015.07.015DOI: 10.1016/j.msard.2015.07.015
Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial. (Journal article)
DiPALS Writing Committee., & DiPALS Study Group Collaborators. (2015). Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial.. The Lancet. Neurology, 14(9), 883-892. doi:10.1016/s1474-4422(15)00152-0DOI: 10.1016/s1474-4422(15)00152-0
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report (Journal article)
Rathnasabapathi, D., Elsone, L., Krishnan, A., Young, C., Larner, A., & Jacob, A. (2015). Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report. JOURNAL OF SPINAL CORD MEDICINE, 38(4), 545-549. doi:10.1179/2045772314Y.0000000283DOI: 10.1179/2045772314Y.0000000283
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease (Journal article)
Ng, L., Khan, F., & Young, C. A. (n.d.). Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. doi:10.1002/14651858.cd011776DOI: 10.1002/14651858.cd011776
Anticholinergics for urinary symptoms in multiple sclerosis (Withdrawn Paper. 2015, Art. no. CD004193) (Journal article)
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2015). Anticholinergics for urinary symptoms in multiple sclerosis (Withdrawn Paper. 2015, Art. no. CD004193). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD004193.pub3DOI: 10.1002/14651858.CD004193.pub3
Why don't they accept non-invasive ventilation?: Insight into the interpersonal perspectives of patients with motor neurone disease (Journal article)
Ando, H., Williams, C., Angus, R. M., Thornton, E. W., Chakrabarti, B., Cousins, R., . . . Young, C. A. (2015). Why don't they accept non-invasive ventilation?: Insight into the interpersonal perspectives of patients with motor neurone disease. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 20(2), 341-359. doi:10.1111/bjhp.12104DOI: 10.1111/bjhp.12104
An assessment of felt-stigma in multiple sclerosis (Conference Paper)
Mills, R. J., Eva, Z., Tennant, A., & Young, C. A. (2015). An assessment of felt-stigma in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 619-620). Retrieved from https://www.webofscience.com/
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis. (Journal article)
Scolding, N., Barnes, D., Cader, S., Chataway, J., Chaudhuri, A., Coles, A., . . . Zajicek, J. (2015). Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.. Practical neurology, 15(4), 273-279. doi:10.1136/practneurol-2015-001139DOI: 10.1136/practneurol-2015-001139
Coping strategies used by people with multiple sclerosis (Conference Paper)
Holland, D., Mills, R. M., Tennant, A., & Young, C. A. (2015). Coping strategies used by people with multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 622-623). Retrieved from https://www.webofscience.com/
Fatigue and quality of life in multiple sclerosis: the mediating effect of activity limitation and the moderating effect of gender and disease type (Conference Paper)
Young, C. A., & Tennant, A. (2015). Fatigue and quality of life in multiple sclerosis: the mediating effect of activity limitation and the moderating effect of gender and disease type. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 340). Retrieved from https://www.webofscience.com/
Neurological Coping Index-MS: a short positive coping scale for multiple sclerosis (Conference Paper)
Mills, R. J., Tennant, A., & Young, C. A. (2015). Neurological Coping Index-MS: a short positive coping scale for multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 620-621). Retrieved from https://www.webofscience.com/
Rasch analysis of the Herth Hope Index in multiple sclerosis (Conference Paper)
Mills, R. J., Tennant, A., & Young, C. A. (2015). Rasch analysis of the Herth Hope Index in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 620). Retrieved from https://www.webofscience.com/
Sexual functioning in multiple sclerosis (Conference Paper)
Young, C. A., & Tennant, A. (2015). Sexual functioning in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 117). Retrieved from https://www.webofscience.com/
The WHOQOL-Bref in MS: impact and satisfaction? (Conference Paper)
Pomeroy, I., Tennant, A., & Young, C. A. (2015). The WHOQOL-Bref in MS: impact and satisfaction?. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 125). Retrieved from https://www.webofscience.com/
The role of positive coping and hopefulness in predicting quality of life in multiple sclerosis (Conference Paper)
Young, C. A., & Tennant, A. (2015). The role of positive coping and hopefulness in predicting quality of life in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 339). Retrieved from https://www.webofscience.com/
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials (Journal article)
Balendra, R., Jones, A., Jivraj, N., Steen, I. N., Young, C. A., Shaw, P. J., . . . Al-Chalabi, A. (2015). Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86(1), 45-49. doi:10.1136/jnnp-2013-306865DOI: 10.1136/jnnp-2013-306865
Worry and self-esteem in multiple sclerosis (Conference Paper)
Zitnik, E., Mills, R. M., Tennant, A., & Young, C. A. (2015). Worry and self-esteem in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 623-624). Retrieved from https://www.webofscience.com/
2014
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. (Journal article)
Filippi, M., Rocca, M. A., Pagani, E., De Stefano, N., Jeffery, D., Kappos, L., . . . ALLEGRO Study Group. (2014). Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.. Journal of neurology, neurosurgery, and psychiatry, 85(8), 851-858. doi:10.1136/jnnp-2013-306132DOI: 10.1136/jnnp-2013-306132
Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) (Journal article)
Young, C. A., Gibbons, C., Pagnini, F., & Friede, T. (n.d.). Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011005DOI: 10.1002/14651858.cd011005
Development of the neurological coping index for multiple sclerosis (NCI-MS) (Conference Paper)
Young, C. A., & Tennant, A. (2014). Development of the neurological coping index for multiple sclerosis (NCI-MS). In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 388-389). Retrieved from https://www.webofscience.com/
Development of the neurological hope index for multiple sclerosis (NHI-MS) (Conference Paper)
Young, C. A., & Tennant, A. (2014). Development of the neurological hope index for multiple sclerosis (NHI-MS). In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 416). Retrieved from https://www.webofscience.com/
Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis. (Journal article)
Ando, H., Chakrabarti, B., Angus, R. M., Cousins, R., Thornton, E. W., & Young, C. A. (2014). Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis.. BMJ supportive & palliative care, 4(1), 50-56. doi:10.1136/bmjspcare-2013-000494DOI: 10.1136/bmjspcare-2013-000494
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis (Journal article)
Jones, A. R., Jivraj, N., Balendra, R., Murphy, C., Kelly, J., Thornhill, M., . . . Al-Chalabi, A. (2014). Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 15(3-4), 285-291. doi:10.3109/21678421.2013.872149DOI: 10.3109/21678421.2013.872149
How do lower urinary tract symptoms affect quality of life in multiple sclerosis: a systematic review of the literature (Conference Paper)
Young, C. A., & Watson, H. L. (2014). How do lower urinary tract symptoms affect quality of life in multiple sclerosis: a systematic review of the literature. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 410). Retrieved from https://www.webofscience.com/
New sleep scales for multiple sclerosis (Conference Paper)
Mills, R. J., Tennant, A., & Young, C. A. (2014). New sleep scales for multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 418-419). Retrieved from https://www.webofscience.com/
Patient reported outcome measures for spasticity - comparison of psychometric properties and correlation with clinician assessment (Conference Paper)
Milinis, K., & Young, C. A. (2014). Patient reported outcome measures for spasticity - comparison of psychometric properties and correlation with clinician assessment. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 21 (pp. 238). Retrieved from https://www.webofscience.com/
Patient reported outcome measures for spasticity: comparison of psychometric properties and correlation with clinician assessment (Conference Paper)
Milinis, K., & Young, C. A. (2014). Patient reported outcome measures for spasticity: comparison of psychometric properties and correlation with clinician assessment. In JOURNAL OF NEUROLOGY Vol. 261 (pp. S164-S165). Retrieved from https://www.webofscience.com/
Psychosocial factors affecting quality of life in multiple sclerosis - a review of the current evidence base (Conference Paper)
Young, C. A., & Edwards, R. (2014). Psychosocial factors affecting quality of life in multiple sclerosis - a review of the current evidence base. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 405-406). Retrieved from https://www.webofscience.com/
Rasch analysis of the Leeds Spasticity Scale in multiple sclerosis (Conference Paper)
Mills, R. J., Milinis, K., Tennant, A., & Young, C. A. (2014). Rasch analysis of the Leeds Spasticity Scale in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 412). Retrieved from https://www.webofscience.com/
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions (Conference Paper)
Milinis, K., & Young, C. A. (2014). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 21 (pp. 28). Retrieved from https://www.webofscience.com/
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions (Conference Paper)
Milinis, K., & Young, C. A. (2014). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. In JOURNAL OF NEUROLOGY Vol. 261 (pp. S22). Retrieved from https://www.webofscience.com/
The Penn State worry questionnaire provides a valid measure of worry across a broad range of disability in multiple sclerosis (Conference Paper)
Pomeroy, I., Tennant, A., & Young, C. A. (2014). The Penn State worry questionnaire provides a valid measure of worry across a broad range of disability in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 391-392). Retrieved from https://www.webofscience.com/
2013
Management of sialorrhoea in motor neuron disease: A survey of current UK practice (Journal article)
Hobson, E. V., McGeachan, A., Al-Chalabi, A., Chandran, S., Crawley, F., Dick, D., . . . McDermott, C. J. (2013). Management of sialorrhoea in motor neuron disease: A survey of current UK practice. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 14(7-8), 521-527. doi:10.3109/21678421.2013.790452DOI: 10.3109/21678421.2013.790452
The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease (Journal article)
Gibbons, C., Thornton, E., Ealing, J., Shaw, P., Talbot, K., Tennant, A., & Young, C. (2013). The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 14(7-8), 537-545. doi:10.3109/21678421.2013.799700DOI: 10.3109/21678421.2013.799700
Assessing social isolation in motor neurone disease: A Rasch analysis of the MND Social Withdrawal Scale (Journal article)
Gibbons, C. J., Thornton, E. W., Ealing, J., Shaw, P. J., Talbot, K., Tennant, A., & Young, C. A. (2013). Assessing social isolation in motor neurone disease: A Rasch analysis of the MND Social Withdrawal Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 334(1-2), 112-118. doi:10.1016/j.jns.2013.08.002DOI: 10.1016/j.jns.2013.08.002
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. (Journal article)
Cudkowicz, M. E., van den Berg, L. H., Shefner, J. M., Mitsumoto, H., Mora, J. S., Ludolph, A., . . . EMPOWER investigators. (2013). Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.. The Lancet. Neurology, 12(11), 1059-1067. doi:10.1016/s1474-4422(13)70221-7DOI: 10.1016/s1474-4422(13)70221-7
RASCH ANALYSIS OF THE WHOQOL-BREF IN POST POLIO SYNDROME (Journal article)
Pomeroy, I. M., Tennant, A., & Young, C. A. (2013). RASCH ANALYSIS OF THE WHOQOL-BREF IN POST POLIO SYNDROME. JOURNAL OF REHABILITATION MEDICINE, 45(9), 873-880. doi:10.2340/16501977-1186DOI: 10.2340/16501977-1186
Rasch analysis of the WHOQOL-BREF in post polio syndrome (Journal article)
Dphil, I. M. P., Tennant, A., & Young, C. A. (2013). Rasch analysis of the WHOQOL-BREF in post polio syndrome. Journal of Rehabilitation Medicine, 45(9), 873-880. doi:10.2340/16501977-1186DOI: 10.2340/16501977-1186
Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia. (Journal article)
Dwivedi, R. A., Dwivedi, R. E., Durnian, J. M., & Young, C. A. (2013). Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia. . BMJ case reports, 2013, bcr2013009363. doi:10.1136/bcr-2013-009363DOI: 10.1136/bcr-2013-009363
Treatment of neuropathic pain for multiple sclerosis (Journal article)
Rog, D., Young, C. A., Hollis, S., & Friede, T. (n.d.). Treatment of neuropathic pain for multiple sclerosis. doi:10.1002/14651858.cd003736.pub2DOI: 10.1002/14651858.cd003736.pub2
Cousins, R., Ando, H., Thornton, E., Chakrabarti, B., Angus, R., & Young, C. (2013). Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need.. Health psychology and behavioral medicine, 1(1), 47-58. doi:10.1080/21642850.2013.848169DOI: 10.1080/21642850.2013.848169
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome (Journal article)
Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Leocani, L., Bajenaru, O., . . . Filippi, M. (2013). Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. MULTIPLE SCLEROSIS JOURNAL, 19(8), 1074-1083. doi:10.1177/1352458512469695DOI: 10.1177/1352458512469695
Is the Epworth Sleepiness Scale Suitable for Use in Stroke? (Journal article)
Mills, R. J., Koufali, M., Sharma, A., Tennant, A., & Young, C. A. (2013). Is the Epworth Sleepiness Scale Suitable for Use in Stroke?. TOPICS IN STROKE REHABILITATION, 20(6), 493-499. doi:10.1310/tsr2006-493DOI: 10.1310/tsr2006-493
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial (Journal article)
Allen, C., Counsell, C., Farrin, A., Al-Chalabi, A., Dickie, B., Leigh, P. N., . . . Majid, T. (2013). Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. LANCET NEUROLOGY, 12(4), 339-345. doi:10.1016/S1474-4422(13)700374DOI: 10.1016/S1474-4422(13)700374
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. (Journal article)
UKMND-LiCALS Study Group., Morrison, K. E., Dhariwal, S., Hornabrook, R., Savage, L., Burn, D. J., . . . Majid, T. (2013). Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.. The Lancet. Neurology, 12(4), 339-345. doi:10.1016/s1474-4422(13)70037-1DOI: 10.1016/s1474-4422(13)70037-1
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS) (Journal article)
Mills, R. J., Calabresi, M., Tennant, A., & Young, C. A. (2013). Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS). MULTIPLE SCLEROSIS JOURNAL, 19(4), 502-505. doi:10.1177/1352458512457840DOI: 10.1177/1352458512457840
Poststroke Fatigue: The Patient Perspective (Journal article)
Young, C. A., Mills, R. J., Gibbons, C., & Thornton, E. W. (2013). Poststroke Fatigue: The Patient Perspective. TOPICS IN STROKE REHABILITATION, 20(6), 478-484. doi:10.1310/tsr2006-478DOI: 10.1310/tsr2006-478
The patient experience of fatigue in motor neurone disease (Journal article)
Gibbons, C. J., Thornton, E. W., & Young, C. A. (2013). The patient experience of fatigue in motor neurone disease. FRONTIERS IN PSYCHOLOGY, 4. doi:10.3389/fpsyg.2013.00788DOI: 10.3389/fpsyg.2013.00788
2012
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome (Journal article)
Meyniel, C., Spelman, T., Jokubaitis, V. G., Trojano, M., Izquierdo, G., Grand'Maison, F., . . . Butzkueven, H. (2012). Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. PLOS ONE, 7(6). doi:10.1371/journal.pone.0038661DOI: 10.1371/journal.pone.0038661
Validation of the Neurological Fatigue Index for stroke (NFI-Stroke) (Journal article)
Mills, R. J., Pallant, J. F., Koufali, M., Sharma, A., Day, S., Tennant, A., & Young, C. A. (2012). Validation of the Neurological Fatigue Index for stroke (NFI-Stroke). HEALTH AND QUALITY OF LIFE OUTCOMES, 10. doi:10.1186/1477-7525-10-51DOI: 10.1186/1477-7525-10-51
Placebo-controlled trial of oral laquinimod for multiple sclerosis. (Journal article)
Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M. A., . . . ALLEGRO Study Group. (2012). Placebo-controlled trial of oral laquinimod for multiple sclerosis.. The New England journal of medicine, 366(11), 1000-1009. doi:10.1056/nejmoa1104318DOI: 10.1056/nejmoa1104318
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome (Journal article)
Young, C. A., Mills, R. J., Woolmore, J., Hawkins, C. P., & Tennant, A. (2012). The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome. MULTIPLE SCLEROSIS JOURNAL, 18(9), 1326-1333. doi:10.1177/1352458512436592DOI: 10.1177/1352458512436592
2011
Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND) (Journal article)
Gibbons, C. J., Mills, R. J., Thornton, E. W., Ealing, J., Mitchell, J. D., Shaw, P. J., . . . Young, C. A. (2011). Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). HEALTH AND QUALITY OF LIFE OUTCOMES, 9. doi:10.1186/1477-7525-9-101DOI: 10.1186/1477-7525-9-101
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS (Journal article)
Freedman, M. S., Bar-Or, A., Oger, J., Traboulsee, A., Patry, D., Young, C., . . . Verco, T. (2011). A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. NEUROLOGY, 77(16), 1551-1560. doi:10.1212/WNL.0b013e318233b240DOI: 10.1212/WNL.0b013e318233b240
Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease (Journal article)
Gibbons, C. J., Mills, R. J., Thornton, E. W., Ealing, J., Mitchell, J. D., Shaw, P. J., . . . Young, C. A. (2011). Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. HEALTH AND QUALITY OF LIFE OUTCOMES, 9. doi:10.1186/1477-7525-9-82DOI: 10.1186/1477-7525-9-82
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31] (Journal article)
Al-Chalabi, A., Shaw, P. J., Young, C. A., Morrison, K. E., Murphy, C., Thornhill, M., . . . Leigh, P. N. (2011). Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC NEUROLOGY, 11. doi:10.1186/1471-2377-11-111DOI: 10.1186/1471-2377-11-111
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. (Journal article)
Khatri, B., Barkhof, F., Comi, G., Hartung, H. -P., Kappos, L., Montalban, X., . . . TRANSFORMS Study Group. (2011). Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.. The Lancet. Neurology, 10(6), 520-529. doi:10.1016/s1474-4422(11)70099-0DOI: 10.1016/s1474-4422(11)70099-0
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis (Journal article)
Young, C. A., Ellis, C., Johnson, J., Sathasivam, S., & Pih, N. (2011). Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD006981.pub2DOI: 10.1002/14651858.CD006981.pub2
Factors predisposing to the development of multiple sclerosis (Journal article)
Young, C. A. (2011). Factors predisposing to the development of multiple sclerosis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 104(5), 383-386. doi:10.1093/qjmed/hcr012DOI: 10.1093/qjmed/hcr012
Adverse cognitive effects of phenytoin in severe brain injury: A case report (Journal article)
Pinder, C., & Young, C. (2011). Adverse cognitive effects of phenytoin in severe brain injury: A case report. BRAIN INJURY, 25(6), 634-637. doi:10.3109/02699052.2011.572946DOI: 10.3109/02699052.2011.572946
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. (Journal article)
Comi, G., Cohen, J. A., Arnold, D. L., Wynn, D., Filippi, M., & FORTE Study Group. (2011). Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.. Annals of neurology, 69(1), 75-82. doi:10.1002/ana.22316DOI: 10.1002/ana.22316
The relationship between fatigue and other clinical features of multiple sclerosis (Journal article)
Mills, R. J., & Young, C. A. (2011). The relationship between fatigue and other clinical features of multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 17(5), 604-612. doi:10.1177/1352458510392262DOI: 10.1177/1352458510392262
2010
Bladder symptoms in multiple sclerosis: a review of pathophysiology and management (Journal article)
Nicholas, R., Young, C., & Friede, T. (2010). Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. EXPERT OPINION ON DRUG SAFETY, 9(6), 905-915. doi:10.1517/14740338.2010.501793DOI: 10.1517/14740338.2010.501793
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. (Journal article)
Comi, G., Abramsky, O., Arbizu, T., Boyko, A., Gold, R., Havrdová, E., . . . LAQ/5063 Study Group. (2010). Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.. Multiple sclerosis (Houndmills, Basingstoke, England), 16(11), 1360-1366. doi:10.1177/1352458510378127DOI: 10.1177/1352458510378127
Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis (Journal article)
Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81(9), 1049-1051. doi:10.1136/jnnp.2008.151340DOI: 10.1136/jnnp.2008.151340
Disability after encephalitis: development and validation of a new outcome score (Journal article)
Lewthwaite, P., Begum, A., Ooi, M. H., Faragher, B., Lai, B. F., Sandaradura, I., . . . Solomon, T. (2010). Disability after encephalitis: development and validation of a new outcome score. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 88(8), 584-592. doi:10.2471/BLT.09.071357DOI: 10.2471/BLT.09.071357
Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T (Journal article)
Mills, R. J., Young, C. A., & Smith, E. T. (2010). Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T. BRITISH JOURNAL OF RADIOLOGY, 83(990), 493-498. doi:10.1259/bjr/65228893DOI: 10.1259/bjr/65228893
Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview (Journal article)
Hugel, H., Pih, N., Dougan, C. P., Rigby, S., & Young, C. A. (2010). Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview. AMYOTROPHIC LATERAL SCLEROSIS, 11(1-2), 104-109. doi:10.3109/17482960902829205DOI: 10.3109/17482960902829205
Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS) (Journal article)
Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). HEALTH AND QUALITY OF LIFE OUTCOMES, 8. doi:10.1186/1477-7525-8-22DOI: 10.1186/1477-7525-8-22
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. (Journal article)
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H. -P., Khatri, B. O., Montalban, X., . . . TRANSFORMS Study Group. (2010). Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.. The New England journal of medicine, 362(5), 402-415. doi:10.1056/nejmoa0907839DOI: 10.1056/nejmoa0907839
2009
Acute amnesia in MS revisited. (Journal article)
Larner, A. J., & Young, C. A. (2009). Acute amnesia in MS revisited.. International MS journal, 16(3), 102-104.
Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif (R) New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results (Journal article)
Giovannoni, G., Barbarash, O., Casset-Semanaz, F., King, J., Metz, L., Pardo, G., . . . Stubinski, B. (2009). Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif (R) New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. MULTIPLE SCLEROSIS JOURNAL, 15(2), 219-228. doi:10.1177/1352458508097299DOI: 10.1177/1352458508097299
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial (Journal article)
Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., . . . Filippi, M. (2009). Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. LANCET, 374(9700), 1503-1511. doi:10.1016/S0140-6736(09)61259-9DOI: 10.1016/S0140-6736(09)61259-9
Fornix damage from solitary subependymal giant cell astrocytoma causing postoperative amnesic syndrome (Journal article)
Ibrahim, I., Young, C. A., & Larner, A. J. (2009). Fornix damage from solitary subependymal giant cell astrocytoma causing postoperative amnesic syndrome. BRITISH JOURNAL OF HOSPITAL MEDICINE, 70(8), 478-479. doi:10.12968/hmed.2009.70.8.43545DOI: 10.12968/hmed.2009.70.8.43545
The effects of an 'exercise and education' programme on exercise self-efficacy and levels of independent activity in adults with acquired neurological pathologies: an exploratory, randomized study (Journal article)
Haworth, J., Young, C., & Thornton, E. (2009). The effects of an 'exercise and education' programme on exercise self-efficacy and levels of independent activity in adults with acquired neurological pathologies: an exploratory, randomized study. CLINICAL REHABILITATION, 23(4), 371-3U2. doi:10.1177/0269215508101728DOI: 10.1177/0269215508101728
Anticholinergics for urinary symptoms in multiple sclerosis. (Journal article)
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2009). Anticholinergics for urinary symptoms in multiple sclerosis.. The Cochrane database of systematic reviews, (1), CD004193. doi:10.1002/14651858.cd004193.pub2DOI: 10.1002/14651858.cd004193.pub2
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis (Journal article)
Mills, R. J., Young, C. A., Nicholas, R. S., Pallant, J. F., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 15(1), 81-87. doi:10.1177/1352458508096215DOI: 10.1177/1352458508096215
Anticholinergics for urinary symptoms in multiple sclerosis (Journal article)
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2009). Anticholinergics for urinary symptoms in multiple sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD004193.pub2DOI: 10.1002/14651858.CD004193.pub2
2008
Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis (Journal article)
Mamutse, G., Woolmore, J., Pye, E., Partridge, J., Boggild, M., Young, C., . . . Hawkins, C. P. (2008). Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 14(9), 1280-1283. doi:10.1177/1352458508094643DOI: 10.1177/1352458508094643
A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis (Journal article)
Rigby, S. A., Thornton, E. W., & Young, C. A. (2008). A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 13, 619-631. doi:10.1348/135910707X241505DOI: 10.1348/135910707X241505
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. (Journal article)
Comi, G., Pulizzi, A., Rovaris, M., Abramsky, O., Arbizu, T., Boiko, A., . . . LAQ/5062 Study Group. (2008). Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.. Lancet (London, England), 371(9630), 2085-2092. doi:10.1016/s0140-6736(08)60918-6DOI: 10.1016/s0140-6736(08)60918-6
Perceptions of goal setting in a neurological rehabilitation unit: A qualitative study of patients, carers and staff (Journal article)
Young, C. A., Manmathan, G. P., & Ward, J. C. R. (2008). Perceptions of goal setting in a neurological rehabilitation unit: A qualitative study of patients, carers and staff. JOURNAL OF REHABILITATION MEDICINE, 40(3), 190-194. doi:10.2340/16501977-0147DOI: 10.2340/16501977-0147
A medical definition of fatigue in multiple sclerosis (Journal article)
Mills, R. J., & Young, C. A. (2008). A medical definition of fatigue in multiple sclerosis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 101(1), 49-60. doi:10.1093/qjmed/hcm122DOI: 10.1093/qjmed/hcm122
Sporadic Creutzfeldt-Jakob disease in two adolescents (Journal article)
Murray, K., Ritchie, D. L., Bruce, M., Young, C. A., Doran, M., Ironside, J. W., & Will, R. G. (2008). Sporadic Creutzfeldt-Jakob disease in two adolescents. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 79(1), 14-18. doi:10.1136/jnnp.2006.104570DOI: 10.1136/jnnp.2006.104570
2007
Oromucosal Delta(9)-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial (Journal article)
Rog, D. J., Nurmikko, T. J., & Young, C. A. (2007). Oromucosal Delta(9)-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial. CLINICAL THERAPEUTICS, 29(9), 2068-2079. doi:10.1016/j.clinthera.2007.09.013DOI: 10.1016/j.clinthera.2007.09.013
Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis (Journal article)
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2007). Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. CLINICAL JOURNAL OF PAIN, 23(6), 473-481. doi:10.1097/AJP.0b013e31805d0c5dDOI: 10.1097/AJP.0b013e31805d0c5d
3D MRI in multiple sclerosis: a study of three sequences at 3 T (Journal article)
Mills, R. J., Young, C. A., & Smith, E. T. S. (2007). 3D MRI in multiple sclerosis: a study of three sequences at 3 T. BRITISH JOURNAL OF RADIOLOGY, 80(953), 307-320. doi:10.1259/bjr/52670770DOI: 10.1259/bjr/52670770
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial (Journal article)
Rovaris, M., Comi, G., Rocca, M. A., Valsasina, P., Ladkani, D., Pieri, E., . . . Filippi, M. (2007). Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial. MULTIPLE SCLEROSIS, 13(4), 502-508. doi:10.1177/1352458506070704DOI: 10.1177/1352458506070704
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. (Journal article)
Woolmore, J. A., Stone, M., Pye, E. M., Partridge, J. M., Boggild, M., Young, C., . . . Strange, R. C. (2007). Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.. Multiple sclerosis (Houndmills, Basingstoke, England), 13(3), 369-375. doi:10.1177/135245850607192DOI: 10.1177/135245850607192
Perceptions of self-efficacy and rehabilitation among neurologically disabled adults (Journal article)
Dixon, G., Thornton, E. W., & Young, C. A. (2007). Perceptions of self-efficacy and rehabilitation among neurologically disabled adults. CLINICAL REHABILITATION, 21(3), 230-240. doi:10.1177/0269215506071784DOI: 10.1177/0269215506071784
Treatment for ataxia in multiple sclerosis. (Journal article)
Mills, R. J., Yap, L., & Young, C. A. (2007). Treatment for ataxia in multiple sclerosis.. The Cochrane database of systematic reviews, (1), CD005029. doi:10.1002/14651858.cd005029.pub2DOI: 10.1002/14651858.cd005029.pub2
Detection of hearing impairment and handicap in Paget's disease of bone using a simple scoring system: A case control study (Journal article)
Young, C. A., Fraser, W. D., & Mackenzie, I. J. (2007). Detection of hearing impairment and handicap in Paget's disease of bone using a simple scoring system: A case control study. BONE, 40(1), 189-193. doi:10.1016/j.bone.2006.07.001DOI: 10.1016/j.bone.2006.07.001
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation (Journal article)
Woolmore, J. A., Stone, M., Pye, E. M., Partridge, J. M., Boggild, M., Young, C., . . . Strange, R. C. (2007). Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. MULTIPLE SCLEROSIS, 13(3), 369-375. doi:10.1177/1352458506071292DOI: 10.1177/1352458506071292
Treatment for ataxia in multiple sclerosis (Journal article)
Mills, R. J., Yap, L., & Young, C. A. (2007). Treatment for ataxia in multiple sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD005029.pub2DOI: 10.1002/14651858.CD005029.pub2
2006
A randomized controlled trial of a health promotion education programme for people with multiple sclerosis (Journal article)
Ennis, M., Thain, J., Boggild, M., Baker, G. A., & Young, C. A. (2006). A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. CLINICAL REHABILITATION, 20(9), 783-792. doi:10.1177/0269215506070805DOI: 10.1177/0269215506070805
Emsley, H. C. A., Young, C. A., & White, R. P. (2006). Circle of Willis variation in a complex stroke presentation: a case report. BMC Neurology, 6(1). doi:10.1186/1471-2377-6-13DOI: 10.1186/1471-2377-6-13
How does current care practice influence the experience of a new diagnosis of motor neuron disease? A qualitative study of current guidelines-based practice (Journal article)
Hugel, H., Grundy, N., Rigby, S., & Young, C. A. (2006). How does current care practice influence the experience of a new diagnosis of motor neuron disease? A qualitative study of current guidelines-based practice. AMYOTROPHIC LATERAL SCLEROSIS, 7(3), 161-166. doi:10.1080/14660820600601051DOI: 10.1080/14660820600601051
Worries and concerns of patients with multiple sclerosis: development of an assessment scale (Journal article)
Thornton, E. W., Tedman, S., Rigby, S., Bashforth, H., & Young, C. (2006). Worries and concerns of patients with multiple sclerosis: development of an assessment scale. MULTIPLE SCLEROSIS, 12(2), 196-203. doi:10.1191/135248506ms1273oaDOI: 10.1191/135248506ms1273oa
Circle of Willis variation in a complex stroke presentation: a case report (Journal article)
Emsley, H. C. A., Young, C. A., & White, R. P. (2006). Circle of Willis variation in a complex stroke presentation: a case report. BMC NEUROLOGY, 6. doi:10.1186/1471-2377-6-13DOI: 10.1186/1471-2377-6-13
2005
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis (Journal article)
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005). Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. NEUROLOGY, 65(6), 812-819. doi:10.1212/01.wnl.0000176753.45410.8bDOI: 10.1212/01.wnl.0000176753.45410.8b
2003
Aids, orthoses, and environmental control systems (Journal article)
Young, C. A. (2003). Aids, orthoses, and environmental control systems. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 13-17. Retrieved from https://www.webofscience.com/
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment (Journal article)
Craig, J., Young, C. A., Ennis, M., Baker, G., & Boggild, M. (2003). A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74(9), 1225-1230. doi:10.1136/jnnp.74.9.1225DOI: 10.1136/jnnp.74.9.1225
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment (Journal article)
Craig, J. (2003). A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. Journal of Neurology, Neurosurgery & Psychiatry, 74(9), 1225-1230. doi:10.1136/jnnp.74.9.1225DOI: 10.1136/jnnp.74.9.1225
Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale (Journal article)
Rigby, S. A., Domenech, C., Thornton, E. W., Tedman, S., & Young, C. A. (2003). Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. MULTIPLE SCLEROSIS JOURNAL, 9(1), 73-81. doi:10.1191/1352458503ms870oaDOI: 10.1191/1352458503ms870oa
Assessment of health needs in multidisciplinary care (Journal article)
Young, C. A. (2003). Assessment of health needs in multidisciplinary care. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74(1), 5. doi:10.1136/jnnp.74.1.5DOI: 10.1136/jnnp.74.1.5
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis (Journal article)
Rovaris, M., Comi, G., Ladkani, D., Wolinsky, J. S., & Filippi, M. (2003). Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. AMERICAN JOURNAL OF NEURORADIOLOGY, 24(1), 75-81. Retrieved from https://www.webofscience.com/
2002
An unusual epistaxis. (Journal article)
Saunders, S., & Young, C. (2002). An unusual epistaxis.. Postgraduate medical journal, 78(924), 619-620. doi:10.1136/pmj.78.924.619DOI: 10.1136/pmj.78.924.619
A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis (Journal article)
Wade, D. T., Young, C. A., Chaudhuri, K. R., & Davidson, D. L. W. (2002). A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73(3), 246-249. doi:10.1136/jnnp.73.3.246DOI: 10.1136/jnnp.73.3.246
2001
Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale (Journal article)
Lee, J. N., Rigby, S. A., Burchardt, F., Thornton, E. W., Dougan, C., & Young, C. A. (2001). Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 191(1-2), 79-85. doi:10.1016/S0022-510X(01)00619-0DOI: 10.1016/S0022-510X(01)00619-0
Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications (Journal article)
Rovaris, M., Comi, G., Rocca, M. A., Wolinsky, J. S., & Filippi, M. (2001). Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications. BRAIN, 124, 1803-1812. doi:10.1093/brain/124.9.1803DOI: 10.1093/brain/124.9.1803
Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. (Journal article)
Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. (2001). Multiple sclerosis (Houndmills, Basingstoke, England), 7(3), 179-183. doi:10.1177/135245850100700308DOI: 10.1177/135245850100700308
Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale (Journal article)
Airlie, J., Baker, G. A., Smith, S. J., & Young, C. A. (2001). Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. CLINICAL REHABILITATION, 15(3), 259-265. doi:10.1191/026921501668362643DOI: 10.1191/026921501668362643
HLA-DRB1 and disease outcome in multiple sclerosis (Journal article)
Weatherby, S. J. M., Thomson, W., Pepper, L., Donn, R., Worthington, J., Mann, C. L. A., . . . Hawkins, C. P. (2001). HLA-DRB1 and disease outcome in multiple sclerosis. JOURNAL OF NEUROLOGY, 248(4), 304-310. doi:10.1007/s004150170205DOI: 10.1007/s004150170205
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. (Journal article)
Comi, G., Filippi, M., & Wolinsky, J. S. (2001). European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.. Annals of neurology, 49(3), 290-297. doi:10.1002/ana.64DOI: 10.1002/ana.64
Anti-spasticity agents for multiple sclerosis. (Journal article)
Shakespeare, D. T., Boggild, M., & Young, C. (2001). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332DOI: 10.1002/14651858.cd001332
Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX): rationale, design and baseline data (Journal article)
Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX): rationale, design and baseline data (2001). Multiple Sclerosis Journal, 7(3), 179-183. doi:10.1177/135245850100700308DOI: 10.1177/135245850100700308
2000
Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS) (Journal article)
Dougan, C. F., Connell, C. O., Thornton, E., & Young, C. A. (2000). Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS). JOURNAL OF THE NEUROLOGICAL SCIENCES, 180(1-2), 86-93. doi:10.1016/S0022-510X(00)00415-9DOI: 10.1016/S0022-510X(00)00415-9
Glutathione S-transferase polymorphisms in MS - Their relationship to disability (Journal article)
Mann, C. L. A., Davies, M. B., Boggild, M. D., Alldersea, J., Fryer, A. A., Jones, P. W., . . . Hawkins, C. P. (2000). Glutathione S-transferase polymorphisms in MS - Their relationship to disability. NEUROLOGY, 54(3), 552-557. doi:10.1212/WNL.54.3.552DOI: 10.1212/WNL.54.3.552
Anti-spasticity agents for multiple sclerosis. (Journal article)
Shakespeare, D. T., Young, C. A., & Boggild, M. (2000). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332DOI: 10.1002/14651858.cd001332
Anti-spasticity agents for multiple sclerosis. (Journal article)
Shakespeare, D. T., Boggild, M., & Young, C. (2003). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332DOI: 10.1002/14651858.cd001332
Multiple sclerosis: care needs for 2000 and beyond (Journal article)
Nodder, D., Chappell, B., Bates, D., Freeman, J., Hatch, J., Keen, J., . . . Young, C. (2000). Multiple sclerosis: care needs for 2000 and beyond. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 93(5), 219-224. doi:10.1177/014107680009300502DOI: 10.1177/014107680009300502
Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis (Journal article)
Weatherby, S. J. M., Mann, C. L. A., Davies, M. B., Carthy, D., Fryer, A. A., Boggild, M. D., . . . Hawkins, C. P. (2000). Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. MULTIPLE SCLEROSIS, 6(1), 32-36. doi:10.1177/135245850000600107DOI: 10.1177/135245850000600107
The role of affect on the perception of disability in multiple sclerosis (Journal article)
Smith, S. J., & Young, C. A. (2000). The role of affect on the perception of disability in multiple sclerosis. CLINICAL REHABILITATION, 14(1), 50-54. doi:10.1191/026921500676724210DOI: 10.1191/026921500676724210
1999
Quality of life assessment in MND: development of a Social Withdrawal Scale (Journal article)
Rigby, S. A., Thornton, E. W., Tedman, S., Burchardt, F., Young, C. A., & Dougan, C. (1999). Quality of life assessment in MND: development of a Social Withdrawal Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 169(1-2), 26-34. doi:10.1016/S0022-510X(99)00212-9DOI: 10.1016/S0022-510X(99)00212-9
The effect of anti-alpha 4 integrin antibody on brain lesion activity in MS (Journal article)
Tubridy, N., Behan, P. O., Capildeo, R., Chaudhuri, A., Forbes, R., Hawkins, C. P., . . . Miller, D. H. (1999). The effect of anti-alpha 4 integrin antibody on brain lesion activity in MS. NEUROLOGY, 53(3), 466-472. doi:10.1212/WNL.53.3.466DOI: 10.1212/WNL.53.3.466
1998
Building a care and research team (Journal article)
Young, C. A. (1998). Building a care and research team. JOURNAL OF THE NEUROLOGICAL SCIENCES, 160, S137-S140. doi:10.1016/S0022-510X(98)00213-5DOI: 10.1016/S0022-510X(98)00213-5
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom (Journal article)
Murphy, N., Confavreux, C., Haas, J., Konig, N., Roullet, E., Sailer, M., . . . Yeardley, H. (1998). Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 65(4), 460-466. doi:10.1136/jnnp.65.4.460DOI: 10.1136/jnnp.65.4.460
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom (Journal article)
Murphy, N., Confavreux, C., Haas, J., Konig, N., Roullet, E., Sailer, M., . . . J-L, M. (1998). Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Journal of Neurology, Neurosurgery & Psychiatry, 65(4), 460-466. doi:10.1136/jnnp.65.4.460DOI: 10.1136/jnnp.65.4.460
Economic evaluation of multiple sclerosis in the UK, Germany and France (Journal article)
Murphy, N., Confavreux, C., Haas, J., Konig, N., Roullet, E., Sailer, M., . . . Merot, J. L. (1998). Economic evaluation of multiple sclerosis in the UK, Germany and France. PHARMACOECONOMICS, 13(5), 607-622. doi:10.2165/00019053-199813050-00013DOI: 10.2165/00019053-199813050-00013
1997
Assessment of depression in patients with motor neuron disease and other neurologically disabling illness (Journal article)
Tedman, B. M., Young, C. A., & Williams, I. R. (1997). Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. JOURNAL OF THE NEUROLOGICAL SCIENCES, 152, S75-S79. doi:10.1016/S0022-510X(97)00249-9DOI: 10.1016/S0022-510X(97)00249-9
1996
Acitretin-induced myopathy (Journal article)
Lister, R. K., Lecky, B. R. F., LewisJones, M. S., & Young, C. A. (1996). Acitretin-induced myopathy. BRITISH JOURNAL OF DERMATOLOGY, 134(5), 989-990. doi:10.1111/j.1365-2133.1996.tb06350.xDOI: 10.1111/j.1365-2133.1996.tb06350.x
1995
CENTRAL PONTINE MYELINOLYSIS - CLINICAL AND MRI CORRELATES (Journal article)
MARTIN, P. J., & YOUNG, C. A. (1995). CENTRAL PONTINE MYELINOLYSIS - CLINICAL AND MRI CORRELATES. POSTGRADUATE MEDICAL JOURNAL, 71(837), 430-432. doi:10.1136/pgmj.71.837.430DOI: 10.1136/pgmj.71.837.430
OBSTRUCTIVE SLEEP-APNEA WITH ARNOLD-CHIARI MALFORMATION (Journal article)
DOHERTY, M. J., SPENCE, D. P. S., YOUNG, C., & CALVERLEY, P. M. A. (1995). OBSTRUCTIVE SLEEP-APNEA WITH ARNOLD-CHIARI MALFORMATION. THORAX, 50(6), 690-691. doi:10.1136/thx.50.6.690DOI: 10.1136/thx.50.6.690
DISEASE PROGRESSION AND PERCEPTIONS OF HEALTH IN PATIENTS WITH MOTOR-NEURON DISEASE (Journal article)
YOUNG, C. A., TEDMAN, B. M., & WILLIAMS, I. R. (1995). DISEASE PROGRESSION AND PERCEPTIONS OF HEALTH IN PATIENTS WITH MOTOR-NEURON DISEASE. JOURNAL OF THE NEUROLOGICAL SCIENCES, 129, 50-53. doi:10.1016/0022-510X(95)00062-7DOI: 10.1016/0022-510X(95)00062-7
1993
Opsoclonus-myoclonus syndrome: an autopsy study of three cases. (Journal article)
Young, C. A., MacKenzie, J. M., Chadwick, D. W., & Williams, I. R. (1993). Opsoclonus-myoclonus syndrome: an autopsy study of three cases.. The European journal of medicine, 2(4), 239-241.
1992
SHORT-TERM-MEMORY IMPAIRMENT IN AN ALERT PATIENT AS A PRESENTATION OF HERPES-SIMPLEX ENCEPHALITIS (Journal article)
YOUNG, C. A., HUMPHREY, P. R. D., GHADIALI, E. J., KLAPPER, P. E., & CLEATOR, G. M. (1992). SHORT-TERM-MEMORY IMPAIRMENT IN AN ALERT PATIENT AS A PRESENTATION OF HERPES-SIMPLEX ENCEPHALITIS. NEUROLOGY, 42(1), 260-261. doi:10.1212/WNL.42.1.260DOI: 10.1212/WNL.42.1.260
1991
EXTRACRANIAL VERTEBRAL ARTERY DISSECTION FOLLOWING TONIC-CLONIC SEIZURE (Journal article)
YOUNG, C. A., CHADWICK, D. W., & HUMPHREY, P. R. D. (1991). EXTRACRANIAL VERTEBRAL ARTERY DISSECTION FOLLOWING TONIC-CLONIC SEIZURE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 54(4), 365-366. doi:10.1136/jnnp.54.4.365DOI: 10.1136/jnnp.54.4.365
UNRECOGNIZED CUSHINGS-SYNDROME AND ADRENAL SUPPRESSION DUE TO TOPICAL CLOBETASOL PROPIONATE (Journal article)
YOUNG, C. A., WILLIAMS, I. R., & MACFARLANE, I. A. (1991). UNRECOGNIZED CUSHINGS-SYNDROME AND ADRENAL SUPPRESSION DUE TO TOPICAL CLOBETASOL PROPIONATE. BRITISH JOURNAL OF CLINICAL PRACTICE, 45(1), 61-62. Retrieved from https://www.webofscience.com/
